GSK 1070916 For Advanced solid tumor
Share: GSK 1070916 NMI-900 , GSK-1070916, GSK-1070916A 4-[3-(4-N,N-Dimethylcarbamylaminophenyl)-1-ethyl-1H-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1H-pyrrolo[2,3-b]pyridine...
View ArticleRecilisib Sodium, EX-RAD
Share: Recilisib Sodium Phase I C16H12ClNaO4S Molecular Weight: 358.771849 g/mol A protein kinase inhibitor potentially for the treatment of acute radiation syndrome....
View ArticleTenatoprazole, テナトプラゾール
Share: Tenatoprazole 泰妥拉唑 Tenatoprazole; 113712-98-4; Ulsacare; Protop; TU 199; TU-199; Molecular Formula: C16H18N4O3S Molecular Weight: 346.40412 g/mol...
View ArticleMK-8876
Share: MK 8876 CAS 1426960-33-9 2-(4-Fluorophenyl)-5-(11-fluoro-6H-pyrido[2′,3′:5,6][1,3]oxazino[3,4-a]indol-2-yl)-N-methyl-6-(N-methylmethanesulfonamido)-1-benzofuran-3-carboxamide...
View ArticleRO-5126766
Share: RO-5126766 946128-88-7 MW 471.46 MF C21H18FN5O5S Phase I 3-[[2-[(Methylaminosulfonyl)amino]-3- fluoropyridin-4-yl]methyl]-4-methyl-7-[(pyrimidin-2-yl)oxy]-...
View ArticlePF-06282999
Share: PF 6282999 Alternative Names: PF-06282999; PF-6282999, PF-06282999 Cas 1435467-37-0 [2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide]...
View ArticleTAK 243
Share: TAK-243, AOB 87172, MLN-7243 CAS 1450833-55-2 Chemical Formula: C19H20F3N5O5S2 Molecular Weight: 519.5142 Sulfamic acid,...
View ArticleRG 6080
Share: RG-6080 Sulfuric acid, mono[(1R,2S,5R)-2-[[(2-aminoethoxy)amino]carbonyl]-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl] ester Phase I A β-lactamase inhibitor potentially for the...
View ArticleCitarinostat
Share: Citarinostat Treatment of Hematological Malignancies, Molecular Formula, C24-H26-Cl-N5-O3, Molecular Weight, 467.9544, RN: 1316215-12-9 UNII: 441P620G3P...
View ArticleDevelopment of a concise, scalable synthesis of a CCR1 antagonist utilizing a...
Share: Development of a concise, scalable synthesis of a CCR1 antagonist utilizing a continuous flow Curtius rearrangement Green Chem., 2017, Advance Article DOI: 10.1039/C6GC03123D, Paper Maurice A....
View Article
More Pages to Explore .....